DEVICE CATEGORY · OAF
Implant, Hearing, Active, Middle Ear, Totally Implanted
Intended to provide useful hearing to persons with sensorineural hearing loss. Indicated for adults with mild to severe sensorineural hearing loss who have a speech discrimination score greater than or equal to 60%.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EsteemP090018/S044 | Envoy Medical Corporation | PMA supplement | Oct 15, 2026 | FDA |
EsteemP090018/S043 | Envoy Medical Corporation | PMA supplement | Jun 3, 2026 | FDA |
EsteemP090018/S042 | Envoy Medical Corporation | PMA supplement | May 21, 2026 | FDA |
| Envoy Medical Corporation | PMA approval | Mar 17, 2010 | FDA |
Source information
Follow the FDA links to view the original records.



